[Problems in treatment of ocular and cerebral vascular disturbances (author's transl)].
With regard to a paper of Leydhecker the basic principles of a combined treatment of ocular and cerebral vascular disturbances with Strophanthin, resp. Digitalis, Vasodilatators, and Hydrocortisone medicaments are again discussed. The influence of hypoxia in vasodilatation, the confirmation of alterations in visual field, as well as the effect of decreased blood viscosity on the circulation are discussed. The most important item, cardiotherapy, is emphasized once again. The peripheral effects of Strophanthin, especially on the brain, are confirmed by communications of other authors. The prognosis of this polypragmatic therapy in long-term observations is also limited.
D001809:Blood Viscosity / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D004071:Digitalis Glycosides / Q000494:pharmacology / Q000627:therapeutic use; D005123:Eye / Q000098:blood supply*; D005128:Eye Diseases / Q000188:drug therapy*; D005901:Glaucoma / Q000188:drug therapy; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use; D014794:Visual Fields / Q000187:drug effects
D004071:Digitalis Glycosides; D014665:Vasodilator Agents
Probleme bei der Behandlung okularer und zerebraler Durchblutungsstörungen 2. Mitteilung